Laboratory preparedness for SARS-CoV-2 and other Winter Respiratory Viruses Webinar

Thursday 24 September 2020



This webinar is in partnership with the Institute of Biomedical Science (IBMS).


Institute of Biomedical Science logo


This event will inform listeners how to validate and quality control their molecular and serology assays for the forthcoming winter respiratory virus season.

The webinar is targeted at but not limited to; Laboratory Managers and Staff, Laboratory QA Mangers and other industry professionals.

Participants attending the webinar will learn:

• How to validate assays
• How to control assays
• How to determine the limit of detection of assays


Questions For The Panel

Once you have registered, you will have the opportunity to submit pre-event questions to our panel of speakers via the Delegate Area. You will be issued with login details on your registration confirmation email. The team will endeavour to answer as many of these questions as they can at the event.

To submit your questions, please log into the Delegate Area and go to Panel Questions in the menu. Delegates will also be able to submit questions on the day.


Twitter - #LabPrepWrv


Please note the agenda is subject to change.

Agenda — full schedule

September 24th, 11:30 - 13:10

Welcome and Introduction

Jennifer Sandle — Quality Manager, Quality Assurance, NIBSC

Laboratory considerations when testing for a novel and evolving virus

Dr Sarah Pitt — Principal Lecturer, School of Pharmacy and Biomolecular Science, University of Brighton, and Chief Examiner Virology, Institute of Biomedical Science

This talk will focus on general laboratory requirements for the forthcoming winter season.

Assay calibration – how sensitive is your assay? and Why assay kit controls are insufficient for day to day assay data monitoring

Claire Morris — Senior Scientist, NIBSC

Rob Anderson — Senior Scientist, NIBSC

This presentation will demonstrate that the numbers are important! The second half of the session will explain why kit controls themselves are not sufficient to meet the requirements of ISO15189 and also how using external controls can help in the day-to-day monitoring of an assay specifically relating to the forthcoming winter season. 

SARS CoV-2 Antibodies-The UK NEQAS Experience

Dina Patel — Scientific Director, UK NEQAS Immunology

The presentation will review the data obtained from various assays, from over 300 participating laboratories

Serology assays and how best to control them

David Padley — Senior Scientist, NIBSC

This talk will show how participating in EQA schemes, whilst important isn’t a substitute for not using run controls, and will discuss how these can help with standardising serology assays. 

Panel session

Closing Remarks



Please check back for registration information.